top of page

WELCOME

Procedure Code Category	CPT Codes	Procedure Code Descriptions	Code Status
AMP	28805	Amputation, foot; transmetatarsal	No Change
AMP	28810	Amputation, metatarsal, with toe, single	No Change
AMP	28820	Amputation, toe; metatarsophalangeal joint	No Change

CPT CODE	PROCEDURE	PRICE
0	CT LIVER PELVIS w/ & w/o contrast,	0
0	CT UROGRAM w/ & w/o contrast	0
73700	CT LOWER EXTREMITY w/o contrast	0
73701	CT LOWER EXTREMITY w/ contrast	0
73702	CT LOWER EXTREMITY w/ & w/o contrast	0
72131	CT LUMBAR SPINE w/o contrast	0
72132	CT LUMBAR SPINE w/ contrast	0
G0297	CT LUNG SCREENING w/o contrast	0
70486	CT MAXILLOFACIAL w/o contrast	0
70490	CT NECK SOFT TISSUE w/o contrast	0

TEST ID	Test Name	CPT Code
CALPR	Calprotectin, Feces	83993
VEGF	Vascular Endothelial Growth Factor, Plasma	83520
TNFA	Tumor Necrosis Factor, Plasma	83520
RUFI	Rufinamide, Serum	80210
MPNR	Myeloproliferative Neoplasm, JAK2 V617F with Reflex to CALR and MPL, Varies	81270-JAK2 (Janus kinase 2) (eg, myeloproliferative disorder) gene analysis, p.Val617Phe (V617F) variant 81219-CALR (calreticulin) (eg, myeloproliferative disorders), gene analysis, common variants in exon 9 (if appropriate) 81339-MPL (MPL proto-oncogene, thrombopoietin receptor) (eg, myeloproliferative disorder) gene analysis; sequence analysis, exon 10 (if appropriate)
FMTT	Familial Mutation, Targeted Testing, Varies	The applicable CPT code will be applied on a case-by-case basis   Gene CPT Code (as appropriate) Any gene not listed below 81403 APC 81202 AR 81174 BRCA1 81215 BRCA2 81217 CACNA1A 81186 CFTR 81221 CSTB 81190 FXN 81289 G6PD 81248 GJB2 81253 HBA1 81258 HBA2 81258 HBB 81362 MECP2 81303 MLH1 81293 MSH2 81296 MSH6 81299 PALB2 81308 PMP22 81326 PMS2 81318 PTEN 81322 SMN1 81337 TP53 81353   81265-Maternal cell contamination (if appropriate) 88233-Tissue culture, skin or solid tissue biopsy (if appropriate) 88235-Tissue culture for amniotic fluid (if appropriate) 88240-Cryopreservation (if appropriate)
CMAPC	Chromosomal Microarray, Autopsy, Products of Conception, or Stillbirth	81229
MDM2F	MDM2 (12q15) Amplification, Well-Differentiated Liposarcoma/Atypical Lipomatous Tumor, FISH, Tissue	88271x2, 88291-DNA probe, each (first probe set), Interpretation and report 88271x2-DNA probe, each; each additional probe set (if appropriate) 88271x1-DNA probe, each; coverage for sets containing 3 probes (if appropriate) 88271x2-DNA probe, each; coverage for sets containing 4 probes (if appropriate) 88271x3-DNA probe, each; coverage for sets containing 5 probes (if appropriate) 88274 w/modifier 52-Interphase in situ hybridization,
FENS	Fentanyl Screen, Random, Urine	80307
FENR	Fentanyl Screen with Reflex, Random, Urine	80307
HCVL	Hepatitis C Virus Antibody Confirmation, Serum	86804
ADNAR	DNA Double-Stranded (dsDNA) Antibodies with Reflex, IgG, Serum	86225 86225-CRITH (if appropriate)

bottom of page